adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)

Medicine Status PIL SPC XPIL EDM - Patient EDM - HCP Legal Category Active Ingredient(s) Company Covid-19 Vaccine Janssen
Updated
PIL 24/01/22 SPC 24/01/22 No--A Janssen Sciences Ireland